Previsioni di mercato del frazionamento del plasma in Europa fino al 2028 - Impatto del COVID-19 e analisi regionale per prodotto (immunoglobulina, albumina, concentrati di fattori di coagulazione, inibitori della proteasi e altri prodotti al plasma), applicazione (neurologia, immunologia, ematologia, terapia intensiva, pneumologia e altro) applicazioni) e utente finale (ospedali e cliniche, laboratori di ricerca clinica e istituti accademici)Â Â Â Â Â Â Â Â

Introduzione al mercato

Il mercato europeo del frazionamento del plasma comprende i mercati consolidati di Germania, Francia, Regno Unito, Spagna, Italia e resto d\'Europa. L’Europa occupa una posizione significativa nel mercato globale del frazionamento del plasma e si stima che registrerà un robusto tasso di crescita nel periodo di previsione. Si prevede che la crescita del mercato nella regione a causa dell’invecchiamento della popolazione, del crescente utilizzo di immunoglobuline per il trattamento di varie malattie croniche, della crescente prevalenza di disturbi immunitari ed emorragici e dell’aumento delle terapie al plasma per la gestione delle malattie, guideranno la crescita del mercato per la regione europea durante il periodo successivo. periodo di previsione.

Nei paesi europei, la pratica medica di varie malattie croniche come disturbi neurologici, disturbi ematologici e malattie respiratorie è cambiata. A causa della diversificazione del personale medico e della decisione di concentrarsi sul trattamento dei malati critici, l’aumento del COVID-19 ha avuto un impatto sull’individuazione e sul trattamento delle malattie. A causa dell’attuale pandemia, molte organizzazioni di ricerca si stanno concentrando maggiormente sugli studi sul COVID-19 e stanno lavorando duramente per comprendere meglio il virus. Alcune agenzie federali della regione hanno preso l’iniziativa di adottare la terapia con il plasma per curare i pazienti affetti da COVID-19. Ad esempio, l’Agenzia nazionale francese per la sicurezza dei medicinali e dei prodotti sanitari (ANSM) ha annunciato che la terapia con plasma immunitario sarà utilizzata nel trattamento dei pazienti critici. Inoltre, la Commissione Europea ha raccomandato l’uso in emergenza della terapia con plasma convalescente per il trattamento dei pazienti critici. Pertanto, l’uso delle terapie al plasma nella gestione di COVID-19 ha avuto in una certa misura un impatto positivo sul mercato. Tuttavia, a causa del COVID-19, la pratica medica complessiva dei disturbi neurologici, dei disturbi ematologici e dei disturbi idiosincratici è cambiata e la maggior parte delle aziende farmaceutiche e biofarmaceutiche stanno enfatizzando lo sviluppo di nuove terapie terapeutiche per il COVID-19, il che sta incidendo negativamente sulla situazione sanitaria. Crescita del mercato.

< p>Panoramica e dinamiche del mercato

Il mercato del frazionamento del plasma in Europa si prevede che crescerà da 6.824,67 milioni di dollari nel 2021 a 10.402,95 milioni di dollari entro il 2028; si stima che crescerà a un CAGR del 6,2% dal 2021 al 2028. Aumento della popolazione geriatrica, aumento dell\'uso di immunoglobuline in varie aree terapeutiche come neurologia, ematologia, malattie genetiche rare e malattie autoimmuni insieme alla crescente domanda di terapie derivate dal plasma per la gestione Si prevede che tutte le malattie aumenteranno il mercato del frazionamento del plasma nel resto d’Europa. Inoltre, diverse aziende in Europa stanno investendo maggiormente in attività di ricerca e sviluppo per sviluppare e lanciare nuovi approcci nelle terapie al plasma per la gestione delle malattie.

Segmenti chiave del mercato

Il mercato europeo del frazionamento del plasma è segmentato in prodotto, applicazione, utente finale e paese. Il mercato europeo del frazionamento del plasma, in base al prodotto, è stato segmentato in immunoglobuline, albumina, concentrati di fattori della coagulazione, inibitori della proteasi e altri. È probabile che il segmento delle immunoglobuline deterrà la quota maggiore del mercato nel 2021. Il mercato europeo del frazionamento del plasma, in base all\'applicazione, è segmentato in neurologia, immunologia, ematologia, terapia intensiva, pneumologia e altri. Nel 2021, è probabile che il segmento Neurologia deterrà la quota maggiore del mercato. Il mercato europeo del frazionamento del plasma, in base all\'utente finale, è segmentato in ospedali e cliniche, laboratori di ricerca clinica, istituti accademici. Nel 2021, il segmento degli ospedali e delle cliniche deterrà probabilmente la quota maggiore del mercato. In base al paese, il mercato europeo del frazionamento del plasma è segmentato in Francia, Germania, Italia, Spagna, Regno Unito e resto d’Europa. Il resto d\'Europa ha detenuto la quota di mercato maggiore nel 2021.

Principali fonti e società elencate

Alcune delle principali fonti primarie e secondarie a cui si fa riferimento per la preparazione di questo rapporto sul mercato del frazionamento del plasma in Europa sono siti Web aziendali, relazioni annuali, relazioni finanziarie, documenti governativi nazionali e database statistici, tra gli altri. Le principali aziende elencate nel rapporto sono Bharat Serums and Vaccines Limited (BSV); Laboratorio Prodotti Bio Ltd.; Biotest AG; CSL limitata; Grifols, SA; Kedrion SpA; Octapharma AG; Sanquin; e SK Plasma.

Motivi per acquistare il rapporto

Comprendere il panorama del mercato europeo del frazionamento del plasma e identificare i segmenti di mercato che hanno maggiori probabilità di garantire un forte ritorno.
Stai al passo con la concorrenza comprendendo il panorama competitivo in continua evoluzione per il mercato europeo del frazionamento del plasma.
Pianifica in modo efficiente operazioni di fusione e acquisizione e accordi di partnership nel mercato europeo del frazionamento del plasma identificando i segmenti di mercato con le vendite probabili più promettenti.
Aiuta a prendere decisioni aziendali consapevoli grazie a un\'analisi percettiva e completa di performance di mercato di vari segmenti del mercato europeo del frazionamento del plasma.
Ottieni previsioni sui ricavi di mercato per il mercato in base ai vari segmenti dal 2021 al 2028 nella regione europea.

Segmentazione del mercato del frazionamento del plasma in Europa

Mercato europeo del frazionamento del plasma - Per prodotto

Immunoglobulina
- Immunoglobulina endovenosa (IVIG)
- Immunoglobulina sottocutanea (SCIG)
Albumina
Concentrati di fattori di coagulazione
Inibitori della proteasi
Altro

Mercato europeo del frazionamento del plasma - A cura di Applicazione

Mercato europeo del frazionamento del plasma - per utente finale

Ospedali e cliniche
Laboratori di ricerca clinica

Istituti accademici

Mercato europeo del frazionamento del plasma - Per paese

Mercato europeo del frazionamento del plasma - Profili aziendali

Bharat Serums and Vaccines Limited (BSV)
Bio Products Laboratory Ltd.
Biotest AG.
CSL Limited
Grifols, SA
Kedrion SpA
Octapharma AG
Sanquin
SK Plasma

TABLE OF CONTENTS
1.           Introduction
1.1         Scope of the Study
1.2         The Insight Partners Research Report Guidance
1.3         Market Segmentation
1.3.1        Europe Plasma Fractionation Market – By Product
1.3.2        Europe Plasma Fractionation Market – By Application
1.3.3        Europe Plasma Fractionation Market – By End User
1.3.4        Europe Plasma Fractionation Market – By Country
2.           Europe Plasma Fractionation Market – Key Takeaways
3.        Research Methodology
3.1         Coverage
3.2         Secondary Research
3.3         Primary Research
4.           Europe Plasma Fractionation Market – Market Landscape
4.1         Overview
4.2         Europe PEST Analysis
4.3         Experts Opinion
5.           Europe Plasma Fractionation Market – Key Market Dynamics
5.1         Market Drivers
5.1.1        Plasma Therapy Being Widely Used
5.1.2        Market is Developing Due to Active Participation of the Key Players
5.2         Market Restraints
5.2.1        Alternate Non-Plasma Substitutes Available
5.3         Future Trends
5.3.1        Novel Diseases Getting Treated By Using Plasma Therapy
5.4         Impact Analysis
6.           Plasma Fractionation Market – Europe Analysis
6.1         Europe Plasma Fractionation Market Revenue Forecast and Analysis
7.           Europe Plasma Fractionation Market Revenue and Forecasts To 2028– by Product
7.1         Overview
7.2         Europe Plasma Fractionation Market, By Product 2021 & 2028 (%)
7.3         Immunoglobulin
7.3.1        Overview
7.3.2        Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.3.2.1          Intravenous Immunoglobulin (IVIG)
7.3.2.1.1          Overview
7.3.2.1.2          Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.3.2.2          Subcutaneous Immunoglobulin (SCIG)
7.3.2.2.1          Overview
7.3.2.2.2          Subcutaneous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.4         Albumin
7.4.1        Overview
7.4.2        Albumin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.5         Coagulation Factor Concentrates
7.5.1        Overview
7.5.2        Coagulation Factor Concentrates: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.6         Protease Inhibitors
7.6.1        Overview
7.6.2        Protease Inhibitors: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.7         Other Plasma Products
7.7.1        Overview
7.7.2        Other Plasma Products: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
8.           Europe Plasma Fractionation Market Revenue and Forecasts To 2028 – Application
8.1         Overview
8.2         Europe Plasma Fractionation Market Share by Application 2021 & 2028 (%)
8.3         Neurology
8.3.1        Overview
8.3.2        Neurology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.4         Immunology
8.4.1        Overview
8.4.2        Immunology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.5         Hematology
8.5.1        Overview
8.5.2        Hematology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.6         Critical Care
8.6.1        Overview
8.6.2        Critical Care: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.7         Pulmonology
8.7.1        Overview
8.7.2        Pulmonology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.8         Other Applications
8.8.1        Overview
8.8.2        Other Applications: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
9.           Europe Plasma Fractionation Market Revenue and Forecasts To 2028 – End User
9.1         Overview
9.2         Europe Plasma Fractionation Market Share by End User 2021 & 2028 (%)
9.3         Hospitals and Clinics
9.3.1        Overview
9.3.2        Hospitals and Clinics: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
9.4         Clinical Research Laboratories
9.4.1        Overview
9.4.2        Clinical Research Laboratories: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
9.5         Academic Institutes
9.5.1        Overview
9.5.2        Academic Institutes: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
10.        Europe Plasma Fractionation Market Revenue and Forecasts to 2028 – Country Analysis
10.1      Overview
10.1.1     Europe: Plasma Fractionation Market, by Country, 2021 & 2028 (%)
10.1.1.1       Germany: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1       Overview
10.1.1.1.2       Germany: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3       Germany: Plasma Fractionation Market, by Product– Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3.1    Germany: Plasma Fractionation Market, by Immunoglobulin Type– Revenue and Forecast to 2028 (USD Million)
10.1.1.1.4       Germany: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.5       Germany: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2       France: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1       Overview
10.1.1.2.2       France: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3       France: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3.1    France: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
10.1.1.2.4       France: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.5       France: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3       UK: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1       Overview
10.1.1.3.2       UK: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3       UK: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3.1    UK: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
10.1.1.3.4       UK: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.5       UK: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4       Spain: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.1       Overview
10.1.1.4.2       Spain: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.3       Spain: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.3.1    Spain: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
10.1.1.4.4       Spain: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.5       Spain: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5       Italy: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.1       Overview
10.1.1.5.2       Italy: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.3       Italy: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.3.1    Italy: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
10.1.1.5.4       Italy: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.5       Italy: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6       Rest of Europe: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.1       Overview
10.1.1.6.2       Rest of Europe: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.3       Rest of Europe: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.3.1    Rest of Europe: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
10.1.1.6.4       Rest of Europe: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.5       Rest of Europe: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
11.        Impact Of COVID-19 Pandemic on Europe Plasma Fractionation Market
11.1      Europe: Impact Assessment Of COVID-19 Pandemic
12.        Plasma Fractionation Market–Industry Landscape
12.1      Overview
12.2      Growth Strategies Followed by Major Market Players (%)
12.3      Organic Developments
12.3.1     Overview
12.4      Inorganic developments
12.4.1     Overview
13.        Company Profiles
13.1      Biotest AG.
13.1.1     Key Facts
13.1.2     Business Description
13.1.3     Products and Services
13.1.4     Financial Overview
13.1.5     SWOT Analysis
13.1.6     Key Developments
13.2      Octapharma AG
13.2.1     Key Facts
13.2.2     Business Description
13.2.3     Products and Services
13.2.4     Financial Overview
13.2.5     SWOT Analysis
13.2.6     Key Developments
13.3      Kedrion S.p.A
13.3.1     Key Facts
13.3.2     Business Description
13.3.3     Products and Services
13.3.4     Financial Overview
13.3.5     SWOT Analysis
13.3.6     Key Developments
13.4      CSL Limited
13.4.1     Key Facts
13.4.2     Business Description
13.4.3     Products and Services
13.4.4     Financial Overview
13.4.5     SWOT Analysis
13.4.6     Key Developments
13.5      Grifols, S.A.
13.5.1     Key Facts
13.5.2     Business Description
13.5.3     Products and Services
13.5.4     Financial Overview
13.5.5     SWOT Analysis
13.5.6     Key Developments
13.6      Bio Products Laboratory Ltd.
13.6.1     Key Facts
13.6.2     Business Description
13.6.3     Products and Services
13.6.4     Financial Overview
13.6.5     SWOT Analysis
13.6.6     Key Developments
13.7      Sanquin
13.7.1     Key Facts
13.7.2     Business Description
13.7.3     Products and Services
13.7.4     Financial Overview
13.7.5     SWOT Analysis
13.7.6     Key Developments
13.8      Bharat Serums and Vaccines Limited (BSV)
13.8.1     Key Facts
13.8.2     Business Description
13.8.3     Products and Services
13.8.4     Financial Overview
13.8.5     SWOT Analysis
13.8.6     Key Developments
13.9      SK Plasma
13.9.1     Key Facts
13.9.2     Business Description
13.9.3     Products and Services
13.9.4     Financial Overview
13.9.5     SWOT Analysis
13.9.6     Key Developments
14.        Appendix
14.1      About The Insight Partners
14.2      Glossary of Terms

LIST OF TABLES
Table 1.             Germany: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 2.             Germany: Plasma Fractionation Market, by Immunoglobulin Type– Revenue and Forecast to 2028 (USD Million)
Table 3.             Germany: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 4.             Germany: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 5.             France: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 6.             France: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
Table 7.             France: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 8.             France: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 9.             UK: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 10.          UK: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
Table 11.          UK: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 12.          UK: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 13.          Spain: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 14.          Spain: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
Table 15.          Spain: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 16.          Spain: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 17.          Italy: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 18.          Italy: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
Table 19.          Italy: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 20.          Italy: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 21.          Rest of Europe: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 22.          Rest of Europe: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
Table 23.          Rest of Europe: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 24.          Rest of Europe: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 25.          Organic Developments Done By Companies
Table 26.          Inorganic developments done by Companies
Table 27.          Glossary of Terms, Plasma Fractionation Market

LIST OF FIGURES
Figure 1.           Europe Plasma Fractionation Market Segmentation
Figure 2.           Europe Plasma Fractionation Market Segmentation, By Country
Figure 3.           Europe Plasma Fractionation Market Overview
Figure 4.           Immunoglobulin Segment Held the Largest Share of the Product Segment in Europe Plasma Fractionation Market
Figure 5.           Germany to Show Significant Growth During Forecast Period
Figure 6.           Europe and PEST Analysis
Figure 7.           Impact Analysis of Drivers and Restraints Pertaining to Europe Plasma Fractionation Market
Figure 8.           Europe Plasma Fractionation Market – Revenue Forecast and Analysis – 2019- 2028
Figure 9.           Europe Plasma Fractionation Market, by Product 2021 & 2028 (%)
Figure 10.        Europe Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 11.        Europe Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 12.        Europe Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 13.        Europe Albumin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 14.        Europe Coagulation Factor Concentrates: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 15.        Europe Protease Inhibitors: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
Figure 16.        Europe Other Plasma Products: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 17.        Europe Plasma Fractionation Market Share by Application 2021 & 2028 (%)
Figure 18.        Europe Neurology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 19.        Europe Immunology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 20.        Europe Hematology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 21.        Europe Critical Care: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 22.        Europe Pulmonology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 23.        Europe Other Applications: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 24.        Europe Plasma Fractionation Market Share by End User 2021 & 2028 (%)
Figure 25.        Europe Hospitals and Clinics: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 26.        Europe Clinical Research Laboratories: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 27.        Europe Academic Institutes: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 28.        Europe: Plasma Fractionation Market, by Key Country – Revenue (2021) (USD Million)
Figure 29.        Europe: Plasma Fractionation Market, by Country, 2021 & 2028 (%)
Figure 30.        Germany: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
Figure 31.        France: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
Figure 32.        UK: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
Figure 33.        Spain: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
Figure 34.        Italy: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
Figure 35.        Rest of Europe: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
Figure 36.        Impact of COVID-19 Pandemic in European Country Markets
Figure 37.          Growth Strategies Followed by Major Market Players (%)

Bharat Serums and Vaccines Limited (BSV)
Bio Products Laboratory Ltd.
Biotest AG.
CSL Limited
Grifols, S.A.
Kedrion S.p.A
Octapharma AG
Sanquin
SK Plasma

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe plasma fractionation market
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Europe plasma fractionation market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the plasma fractionation market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Report Code

Full Name

Country Name

Email Id

Phone Number

Job Title

Company

Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name Published Date

Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv.. May 2022

Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P.. May 2022

Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat.. May 2022

Report Name	Published Date
Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv..	May 2022
Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P..	May 2022
Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF
Inquire before Buying Inquire for Discount

Subscription Member Price: FREE
Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.